Papers/PMID:40647269
Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial.
Nutrients2025The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
curcumin — no detected effect on fasting blood glucose
LikelyGrade B, Likely. Human evidence with one recorded weakness, or capped at B by its design or by unread numbers.FindingNull resultreplicated ×1“In contrast, the fasting blood glucose levels remained the same in both the curcumin ( p = 0.154, 95% CI: −7.547 to 0.976) and placebo group ( p > 0.999, 95% CI: −5.537 to 5.093).”
Quoted verbatim from Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- 80 mg curcumin (Longvida lipophilic matrix), one capsule daily
- Population
- adults aged 60 years or older with prediabetes or overweight/obesity; co-primary endpoint
Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial.2025PMID:40647269Permalink